Management of Type 2 Diabetes in Your Older Patients

Moderator: Amit A. Shah, MD, FACP
Supported by an educational grant from sanofi-aventis U.S. Inc.
Learning Objectives: (1) outline effective culturally competent strategies for patient education, outreach and management of Type 2 Diabetes in different communities; (2) describe the co-morbidities and geriatric syndromes common among older adults with T2DM and understand the need to take an individualized management approach to care; and (3) describe appropriate goals for glucose control in the older adult and describe the risks and benefits of treatment options.

Effective 9/23/10
FDA significantly restricts use of rosiglitazone (Avandia, Avandaryl, Avandameta)
Due to data suggesting higher cardiovascular risk, such as heart attack and stroke, individuals with Type 2 diabetes who are not currently taking rosiglitazone can only be prescribed the medication if they are unable to achieve glycemic control with an alternative medication. Rosiglitazone will only be available to individuals who are currently taking the medication if they appear to be benefiting from the drug and have been counseled on the risks.

For further information:
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm226956.htm

http://healthpolicyandreform.nejm.org/?p=12698&query=OF

Culturally Competent Patient Education, Outreach and Management
Speaker TBA

Developing a Diabetes Care Plan in Older Patients with Comorbidities
Amit A. Shah, MD, FACP

Treatment of Type 2 Diabetes in Your Older Patient
John M. Stafford, MD, PhD